PSTI : Summary for Pluristem Therapeutics, Inc. - Yahoo Finance

U.S. Markets close in 3 hrs 10 mins

Pluristem Therapeutics Inc. (PSTI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.14+0.02 (+1.56%)
As of 12:50PM EST. Market open.
People also watch
CUROPXAOSIRATHXCYTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.12
Open1.13
Bid1.13 x 3700
Ask1.14 x 4100
Day's Range1.12 - 1.14
52 Week Range1.04 - 1.85
Volume155,885
Avg. Volume373,957
Market Cap109.52M
Beta0.19
PE Ratio (TTM)-3.85
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pluristem Therapeutics, Inc. :PSTI-US: Earnings Analysis: Q2, 2017 By the Numbers
    Capital Cube57 minutes ago

    Pluristem Therapeutics, Inc. :PSTI-US: Earnings Analysis: Q2, 2017 By the Numbers

    Categories: Earnings Analysis Yahoo Finance Click here to see latest analysis Pluristem Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -6.61 million. The company employs relatively high amounts of assets (with a turnover of 0x compared to peer median of 0.04x) while generating profit ... Read more (Read more...)

  • GlobeNewswire9 days ago

    Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook

    HAIFA, Israel, Feb. 13, 2017-- Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments for the ...

  • Associated Press13 days ago

    Pluristem reports 2Q loss

    On a per-share basis, the Haifa, Israel-based company said it had a loss of 8 cents. The company's shares closed at $1.15. A year ago, they were trading at 80 cents. _____ This story was generated by Automated ...